• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物引起 QT 间期延长的遗传和分子方面。

Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation.

机构信息

School of Medicine and Health Sciences, Universidad del Rosario, Bogotá 111221, Colombia.

GENIUROS Research Group, Center for Research in Genetics and Genomics (CIGGUR), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá 111221, Colombia.

出版信息

Int J Mol Sci. 2021 Jul 28;22(15):8090. doi: 10.3390/ijms22158090.

DOI:10.3390/ijms22158090
PMID:34360853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8347245/
Abstract

Long QT syndromes can be either acquired or congenital. Drugs are one of the many etiologies that may induce acquired long QT syndrome. In fact, many drugs frequently used in the clinical setting are a known risk factor for a prolonged QT interval, thus increasing the chances of developing torsade de pointes. The molecular mechanisms involved in the prolongation of the QT interval are common to most medications. However, there is considerable inter-individual variability in drug response, thus making the application of personalized medicine a relevant aspect in long QT syndrome, in order to evaluate the risk of every individual from a pharmacogenetic standpoint.

摘要

长 QT 综合征可以是获得性的,也可以是先天性的。药物是导致获得性长 QT 综合征的众多病因之一。事实上,许多在临床中经常使用的药物是导致 QT 间期延长的已知危险因素,从而增加尖端扭转型室性心动过速的发生几率。涉及 QT 间期延长的分子机制在大多数药物中是常见的。然而,药物反应在个体之间存在相当大的差异,因此从药物遗传学的角度评估每个个体的风险,使个性化医学的应用成为长 QT 综合征的一个相关方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7a/8347245/e1f8be713462/ijms-22-08090-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7a/8347245/e1f8be713462/ijms-22-08090-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff7a/8347245/e1f8be713462/ijms-22-08090-g001.jpg

相似文献

1
Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation.药物引起 QT 间期延长的遗传和分子方面。
Int J Mol Sci. 2021 Jul 28;22(15):8090. doi: 10.3390/ijms22158090.
2
[Drug induced QT prolongation].[药物诱导的QT间期延长]
Wien Klin Wochenschr. 2008;120(5-6):128-35. doi: 10.1007/s00508-008-0940-6.
3
Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.常见基因变异风险评分与药物诱导的QT间期延长及尖端扭转型室速风险相关:一项初步研究。
Circulation. 2017 Apr 4;135(14):1300-1310. doi: 10.1161/CIRCULATIONAHA.116.023980. Epub 2017 Feb 17.
4
QT interval and drug therapy.QT间期与药物治疗。
Drug Ther Bull. 2016 Mar;54(3):33-6. doi: 10.1136/dtb.2016.3.0390.
5
Clinical relevance and management of drug-related QT interval prolongation.药物相关性QT间期延长的临床意义及管理
Pharmacotherapy. 2003 Jul;23(7):881-908. doi: 10.1592/phco.23.7.881.32730.
6
Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome.性别是药物不良反应的一个风险因素吗?以药物诱发的长QT综合征为例。
Drug Saf. 2001;24(8):575-85. doi: 10.2165/00002018-200124080-00002.
7
Drug-induced QT Interval Prolongation in the Intensive Care Unit.重症监护病房中的药物性QT间期延长
Curr Clin Pharmacol. 2017;12(4):210-222. doi: 10.2174/1574884713666180223123947.
8
Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes.预测不可预测的:药物引起的 QT 间期延长和尖端扭转型室性心动过速。
J Am Coll Cardiol. 2016 Apr 5;67(13):1639-1650. doi: 10.1016/j.jacc.2015.12.063.
9
Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.药物诱导的尖端扭转型室性心动过速的药物遗传学方面:改善临床药物开发和处方的潜在工具。
Drug Saf. 2004;27(3):145-72. doi: 10.2165/00002018-200427030-00001.
10
[Adverse drug reactions. QT-prolongation and torsade-de-pointes arrhythmias].
Dtsch Med Wochenschr. 2002 May 10;127(19):1022-4. doi: 10.1055/s-2002-28319.

引用本文的文献

1
A Description of QT-Interval Prolonging Drug Interactions with Fluoroquinolones in Older Women with Uncomplicated Urinary Tract Infections.老年单纯性尿路感染女性中喹诺酮类药物与延长QT间期药物相互作用的描述
Can Geriatr J. 2025 Sep 3;28(3):228-234. doi: 10.5770/cgj.28.835. eCollection 2025 Sep.
2
Pharmacogenomic markers associated with drug-induced QT prolongation: a systematic review.与药物性QT间期延长相关的药物基因组学标志物:一项系统综述。
Pharmacogenomics. 2025 Jan-Feb;26(1-2):53-72. doi: 10.1080/14622416.2025.2481025. Epub 2025 Mar 21.
3
Efficacy and safety of second‑generation FLT3 inhibitors in acute myeloid leukemia: A systematic review and meta‑analysis of randomized controlled trials.

本文引用的文献

1
Mechanism of C-type inactivation in the hERG potassium channel.人乙醚 - 去极化激活的钾离子通道(hERG钾通道)中C型失活的机制。
Sci Adv. 2021 Jan 29;7(5). doi: 10.1126/sciadv.abd6203. Print 2021 Jan.
2
Cardiovascular Toxicity of Targeted Therapies for Cancer: An Overview of Systematic Reviews.癌症靶向治疗的心血管毒性:系统评价概述
JNCI Cancer Spectr. 2020 Aug 24;4(6):pkaa076. doi: 10.1093/jncics/pkaa076. eCollection 2020 Dec.
3
Comparison of two algorithms to support medication surveillance for drug-drug interactions between QTc-prolonging drugs.
第二代FLT3抑制剂治疗急性髓系白血病的疗效与安全性:一项随机对照试验的系统评价与Meta分析
Mol Clin Oncol. 2024 Oct 11;21(6):93. doi: 10.3892/mco.2024.2791. eCollection 2024 Dec.
4
Rapid changes of mRNA expressions of cardiac ion channels affected by Torsadogenic drugs influence susceptibility of rat hearts to arrhythmias induced by Beta-Adrenergic stimulation.心动过速致心律失常药物引起的心肌离子通道 mRNA 表达的快速变化影响β肾上腺素刺激诱导的大鼠心脏心律失常易感性。
Pharmacol Res Perspect. 2023 Oct;11(5):e01134. doi: 10.1002/prp2.1134.
5
Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy.口服抗肿瘤治疗药物剂量调整及心脏毒性和脂质代谢不良事件管理指南
Front Oncol. 2023 Aug 25;13:1220305. doi: 10.3389/fonc.2023.1220305. eCollection 2023.
6
Unraveling Structural Alerts in Marketed Drugs for Improving Adverse Outcome Pathway Framework of Drug-Induced QT Prolongation.解析已上市药物中的结构警示信号,以改善药物致 QT 间期延长的不良结局途径框架。
Int J Mol Sci. 2023 Apr 5;24(7):6771. doi: 10.3390/ijms24076771.
7
The three-dimensionality of the hiPSC-CM spheroid contributes to the variability of the field potential.人诱导多能干细胞来源的心肌细胞(hiPSC-CM)球体的三维结构导致了场电位的变异性。
Front Physiol. 2023 Mar 21;14:1123190. doi: 10.3389/fphys.2023.1123190. eCollection 2023.
8
Recommendations on the use of azole antifungals in hematology-oncology patients.血液病-肿瘤患者中唑类抗真菌药物的应用建议。
Rev Esp Quimioter. 2023 Jun;36(3):236-258. doi: 10.37201/req/013.2023. Epub 2023 Apr 5.
9
Extremely dangerous hypopituitarism related long QT syndrome and transient ST-segment elevation: A case report.极其危险的垂体功能减退相关长QT综合征和短暂性ST段抬高:一例报告
SAGE Open Med Case Rep. 2023 Jan 3;11:2050313X221147194. doi: 10.1177/2050313X221147194. eCollection 2023.
10
Prevalence of potential drug - drug interactions in the cardiothoracic intensive care unit patients in a Chinese tertiary care teaching hospital.中国一家三级教学医院心胸重症监护病房患者潜在药物相互作用的发生率。
BMC Pharmacol Toxicol. 2022 Jun 14;23(1):39. doi: 10.1186/s40360-022-00582-6.
比较两种算法以支持 QTc 延长药物相互作用的药物监测。
Int J Med Inform. 2021 Jan;145:104329. doi: 10.1016/j.ijmedinf.2020.104329. Epub 2020 Nov 4.
4
Functional Impact of BeKm-1, a High-Affinity hERG Blocker, on Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells.BeKm-1(一种高亲和力的 hERG 阻断剂)对人诱导多能干细胞衍生的心肌细胞的功能影响。
Int J Mol Sci. 2020 Sep 28;21(19):7167. doi: 10.3390/ijms21197167.
5
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association.药物性心律失常:美国心脏协会的科学声明。
Circulation. 2020 Oct 13;142(15):e214-e233. doi: 10.1161/CIR.0000000000000905. Epub 2020 Sep 15.
6
Risk Assessment of Drug-Induced Long QT Syndrome for Some COVID-19 Repurposed Drugs.某些 COVID-19 再利用药物致药物性长 QT 综合征的风险评估。
Clin Transl Sci. 2021 Jan;14(1):20-28. doi: 10.1111/cts.12882. Epub 2020 Nov 18.
7
QT interval prolongation and with donepezil, rivastigmine and galantamine.QT间期延长以及与多奈哌齐、卡巴拉汀和加兰他敏有关。 (原句表述不太完整准确,翻译可能会稍显生硬,你可以检查下原文是否完整)
Ther Adv Drug Saf. 2020 Aug 17;11:2042098620942416. doi: 10.1177/2042098620942416. eCollection 2020.
8
QT prolongation with hydroxychloroquine and azithromycin for the treatment of COVID-19: The need for pharmacogenetic insights.羟氯喹啉和阿奇霉素治疗新冠肺炎时的QT间期延长:对药物遗传学见解的需求。
J Cardiovasc Electrophysiol. 2020 Oct;31(10):2793-2794. doi: 10.1111/jce.14722. Epub 2020 Sep 1.
9
COVID-19 infection and cardiac arrhythmias.COVID-19 感染与心律失常。
Trends Cardiovasc Med. 2020 Nov;30(8):451-460. doi: 10.1016/j.tcm.2020.08.002. Epub 2020 Aug 16.
10
Revisiting the hERG safety margin after 20 years of routine hERG screening.重温 20 年常规 hERG 筛选后的 hERG 安全性裕度。
J Pharmacol Toxicol Methods. 2020 Sep;105:106900. doi: 10.1016/j.vascn.2020.106900. Epub 2020 Aug 5.